Delivery Order SPE2DB22D1202-SPE2DB24FVMW3

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a $7,244.82 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Concerta ER 27 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $13,165.57 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,338,552 units of Concerta ER 27 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a $5,505.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,061,908 units of the drug Concerta ER 18 mg tablets. The contract has an ultimate completion date of December 12, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,823.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565684012 CONCERTA ER 36 MG TABLET 100S. This contract has an ultimate completion date of September 5, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 tablets of Concerta ER 36 mg. The $19,287.31 firm fixed-price contract has a completion date of May 5, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,970,697 units of Concerta ER 54 mg tablets. The contract has a ceiling value of $6,173.01 and a period of performance through March 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,367.53 contract is for the delivery of Concerta ER 27 mg tablets. The contract is not set aside and has an ultimate completion date of June 9, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Concerta ER 27 mg tablets. The contract, valued at $6,832.56, is a firm-fixed price delivery order with a completion date of July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp (a subsidiary of AmerisourceBergen Corporation) for the provision of Concerta ER 54mg tablets. The contract has a ceiling value of $7,126.95 and a period of performance through April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which was issued under an existing Indefinite Delivery Contract (IDC) valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,971,395 units of Concerta ER 27 mg tablets. The $2,596.17 contract has a performance period through March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous DLA medical supply contracts, including an indefinite delivery contract (IDC) valued up to $999,999,999.00...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVMW3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to Amerisourcebergen Drug Corp for the supply of Concerta ER 27 mg tablets. The contract, valued at $5,774.75, has a completion date of September 9, 2024. Amerisourcebergen, a large pharmaceutical distributor, is providing these prescription medications through an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999. This contract supports the DLA's mission to provide medical supplies and pharmaceuticals to military treatment facilities and other federal healthcare programs. The award does not have a set-aside designation.

Generated 12/6/24, 9:33 AM